Lung and Tracheal Tissue Expected to Aid Respiratory Disease Research
By Gerald M. Slutzky, PhD Posted on 25 Nov 2016 |
Image: Researchers have created a tissue-engineered model of the lung and trachea to help study disease processes (Photo courtesy of the Children’s Hospital Los Angeles).
By modifying a technique for growing cultured intestinal tissue, researchers have developed a tissue-engineered model of the lung and trachea, which contains the diverse cell types present in the human respiratory tract.
Since the cellular and molecular mechanisms that underpin regeneration of the human lung are unknown, study of lung repair has been slowed by the necessity of using model systems that exclude key components.
Investigators at Children's Hospital Los Angeles (CA, USA) had previously developed tissue-engineered small intestine (TESI) and showed that this regenerated tissue was functional and contained all of the key components of the native tissue. Based on this expertise, they hypothesized that multicellular epithelial and mesenchymal cell clusters or lung organoid units (LuOU) could be transplanted to recapitulate proximal and distal cellular structures of the native lung and airways.
The investigators described in the October 31, 2016, online edition of the journal Tissue Engineering Part C: Methods how they transplanted postnatal tissues from whole mouse and human lung, distal mouse lung, as well as mouse and human trachea onto biodegradable polymer scaffolds. The tissue obtained by using this strategy was termed tissue-engineered lung or TELu, and it contained the necessary cell types consistent with native adult lung tissue and demonstrated proliferative cells at two and four weeks. This technique recapitulated important elements of both mouse and human lungs featuring key components of both the proximal and distal lung regions.
"We think that understanding lung regeneration in this model will allow several steps forward," said senior author Dr. Tracy Grikscheit, associate professor of surgery at Children's Hospital Los Angeles. "For example, advanced stages of disease can be studied with TELu that would be impossible to fully understand in our patients. Likewise, we can more quickly apply many more therapies in this model in order to – hopefully – deliver future human therapies."
Related Links:
Children's Hospital Los Angeles
Since the cellular and molecular mechanisms that underpin regeneration of the human lung are unknown, study of lung repair has been slowed by the necessity of using model systems that exclude key components.
Investigators at Children's Hospital Los Angeles (CA, USA) had previously developed tissue-engineered small intestine (TESI) and showed that this regenerated tissue was functional and contained all of the key components of the native tissue. Based on this expertise, they hypothesized that multicellular epithelial and mesenchymal cell clusters or lung organoid units (LuOU) could be transplanted to recapitulate proximal and distal cellular structures of the native lung and airways.
The investigators described in the October 31, 2016, online edition of the journal Tissue Engineering Part C: Methods how they transplanted postnatal tissues from whole mouse and human lung, distal mouse lung, as well as mouse and human trachea onto biodegradable polymer scaffolds. The tissue obtained by using this strategy was termed tissue-engineered lung or TELu, and it contained the necessary cell types consistent with native adult lung tissue and demonstrated proliferative cells at two and four weeks. This technique recapitulated important elements of both mouse and human lungs featuring key components of both the proximal and distal lung regions.
"We think that understanding lung regeneration in this model will allow several steps forward," said senior author Dr. Tracy Grikscheit, associate professor of surgery at Children's Hospital Los Angeles. "For example, advanced stages of disease can be studied with TELu that would be impossible to fully understand in our patients. Likewise, we can more quickly apply many more therapies in this model in order to – hopefully – deliver future human therapies."
Related Links:
Children's Hospital Los Angeles
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples